TP-300

N/A

Report date: 2022/05/17 17:50:44
NME

Base Information

Drug NameTP-300
Drug Alias NameTP-300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsStomach NeoplasmsColorectal NeoplasmsEsophageal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChugai Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsStomach NeoplasmsColorectal NeoplasmsEsophageal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A